---
title: "Weekly Recap | Tpg -9.42%, president exits amid Lyric sale"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298795415.md"
description: "TPG fell 9.42% this week to close at $47.69, while the S&P 500 slipped 0.8%, leaving the stock roughly 8.62 percentage points behind the benchmark. The move was a steady pullback: after opening Tuesday at $52.15, the shares slid below $50 on Wednesday on heavy volume of 3.93m shares, touched a weekly low of $46.87 on Thursday, and steadied to $47.69 on Friday, with weekly amplitude of 11.72%."
datetime: "2026-09-12T06:54:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298795415.md)
  - [en](https://longbridge.com/en/news/298795415.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298795415.md)
generator: "portal-rs"
---

# Weekly Recap | Tpg -9.42%, president exits amid Lyric sale

## The Week

TPG fell 9.42% this week to close at $47.69, while the S&P 500 slipped 0.8%, leaving the stock roughly 8.62 percentage points behind the benchmark. The move was a steady pullback: after opening Tuesday at $52.15, the shares slid below $50 on Wednesday on heavy volume of 3.93m shares, touched a weekly low of $46.87 on Thursday, and steadied to $47.69 on Friday, with weekly amplitude of 11.72%.

## Key Events

The main story this week was executive turnover and asset moves. On 9 September, TPG President Todd Sisitsky stepped down and left the board, while TPG Private Equity Opportunities named CEO Jack Weingart as board chair. CVC then tapped Sisitsky as co-CEO in its own leadership transition. On 10 September, an exclusive report said TPG is exploring a $5bn sale of healthcare software company Lyric. In parallel, UnitedHealth’s Optum overhaul drew TPG in, with the CFO saying the firm did not need the cash.

## Analyst Ratings

Across 16 covering firms, 7 rate the stock buy, 6 rate it over, and 3 rate it hold; none give under or sell, with a consensus recommendation of buy. The consensus target price sits at $60.4375, about 26.73% above the latest price of $47.69. Individual targets range from $46 to $68, showing wide dispersion. Within the asset management and custody banking industry, the stock ranks 11th out of 109 names.

## The Week Ahead

Macro data comes in thick next week. The New York Fed manufacturing index lands on 15 September, with the prior reading at 20.6 and consensus at 14.75. On 16 September, retail sales ex-autos, retail control, the NAHB housing market index, import prices, and EIA crude inventories are all due. Retail sales carries a prior of -0.6 and forecast of 0.9, so the market will be watching whether consumer spending holds up. On the company side, the leadership handover and any progress on the Lyric sale remain to be detailed.

## In Short

The week’s tension is the gap between a broadly constructive sell-side view and a one-way decline in the shares. Thirteen of 16 brokers rate the stock buy or over, and the consensus target sits more than a quarter above spot, yet the price dropped nearly 10%. In the latest session, small-lot flow was net positive while large and medium money turned net sellers. The stock carries a high P/E near 106x and a P/B of 14.8x. What comes next depends on the leadership transition settling and the Lyric sale giving a clearer path to unlocking value, while retail data will set the tone for risk appetite.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [TPG.US](https://longbridge.com/en/quote/TPG.US.md)

## Related News & Research

- [TPG (NASDAQ:TPG) Coverage Initiated by Analysts at Wells Fargo & Company](https://longbridge.com/en/news/300856980.md)
- [RBC Capital Reaffirms Their Buy Rating on TPG (TPG)](https://longbridge.com/en/news/301090512.md)
- [TPG’s $10B Climate Fund Shows Investors Aren’t Giving Up on the Energy Transition](https://longbridge.com/en/news/300720146.md)
- [Micron Stock Price Forecast: Unlikely to Break Record High of $1,255 in Short Term Amid Taiwan Strike Risk](https://longbridge.com/en/news/301253443.md)
- [Why a longtime skeptic of Palantir's stock is finally saying it's time to buy](https://longbridge.com/en/news/301303576.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**